Methods: This randomized, controlled and prospectively designed study included two independent groups, consisting of 27 nonpulsatile (NP) and 24 pulsatile (P) cases who had undergone open heart surgical procedures. Demographic and hemodynamic data were recorded. The effects of perfusion types were evaluated in terms of free hemoglobin (free Hb), haptoglobin (Hp), lactate dehydrogenase (LDH), potassium (K+), platelet number (plt) and urine Hb. These levels were measured in preoperative period, 30 and 60 minutes after initiation of cardiopulmonary bypass (CPB), two and 24 hours postoperatively. Also, total chest drainage and transfusion requirement were assessed.
Results: Demographic and hemodynamic measurements did not differ between the groups. The mean arterial pressure of the NP group was statistically higher at the 30th minute. Free Hb, Hp, LDH and K+ levels did not differ in both groups in all time points. The urine Hb levels were significantly higher in the P group in the 30th minute. There was no difference regarding total chest drainage amounts and number of transfused erythrocyte cell packages.
Conclusion: A clinically nonsignificant hemolytic effect of pulsatile perfusion can be outlined, although it is mentioned only in the urine Hb measurements on the laboratory basis.
Consent: After informed consent and approval from the local ethics committee, 51 adult patients undergoing elective, first-time coronary artery bypass grafting (CABG) were randomly assigned either to the control or the study group. Exclusion criteria included anemia along with cerebrovascular and chronic renal diseases.
Patient population and operation: The study included 51 patients who underwent open heart procedures between February and May of 2010. Twenty-seven of the patients comprised the control (nonpulsatile; NP) group while the other 24 made up the study (pulsatile; P) group. The two groups were comparable in gender, age, body mass index (BMI), duration of CPB, and aortic cross-clamp (ACC) periods. The patient characteristics and general data are shown in Table 1. Methods of cannulation, surgery, and anesthetic techniques did not differ for the two groups during the study period. Arterial and central venous in addition to rectal and esophageal temperature and urine output were monitored throughout the operation. After a standard midline sternotomy, aortic and bicaval cannulation were done.
Cardiopulmonary bypass: The pump circuit consisted of an oxygenator (Dideco EVO, Mirandola, Italy) with a 40 μm arterial line filter (Dideco D734, Mirandola, Italy) and a roller pump (Stockert S5 D-80939, Munchen, Germany). A Ringer solution constituted the main substance of the prime solution. The prime volume of the CPB circuit was 1200-1350 mL. If the estimated hematocrit level was less than 2%, packed blood cells were added to the circuit. The flow rates were maintained between 1.2 and 2.4 L/m2/min, depending on the weight. Myocardial preservation was achieved with an intermittent cold sanguineous crystalloid cardioplegic solution during ACC. Circulatory arrest was not used.
Pulsatility: As usual, the CPB was started in the nonpulsatile mode, but in the P group, the flow transformed to the pulsatile type during the ACC period. After termination of the cross-clamp, flow gained its nonpulsatile character again. Body temperature, flow index, mean arterial pressure and systolic-diastolic pressure difference were all recorded.
Parameters: The following variables were noted and compared in both groups: Free Hb, Hp, LDH, K+, Plt, uHb. These parameters were documented in five different periods: the preoperative period, 30 and 60 minutes after initiating CPB, and at 2 and 24 hours postoperatively. Additionally, total chest drainage and number of transfused erythrocyte cell packages were recorded.
Data analysis
The statistical calculations were performed using the
Statistical Package for the Social Sciences (SPSS)
for Windows, release 10.1 Student version (SPSS
Inc., Chicago, IL, USA). Student’s t-test was used for
comparing both independent groups. The probability (p)
of less than 0.05 was considered significant, and all p
values were two-tailed. The results in the text and in the
tables were expressed as arithmetical mean + standard
deviation.
Table 1: Demographic and perioperative parameters
Hemodynamic variations: Body temperatures at the 30th and 60th minutes of perfusion did not differ between the groups. Though the difference was insignificant, the flow indexes at 30 and 60 minutes were higher in the P group. The mean arterial pressure of the NP group was statistically higher than the P group at the 30th minute of perfusion (64.9±8.9 versus 56.3±5.6 mmHg). There was no difference at the 60th minute. The pressure differences between systolic and diastolic levels were recorded at the 30 and 60th minutes, and in both groups, the value was significantly higher in the P group (roughly 17 versus 6 mmHg). This is an expected outcome of the pulsatility (Table 1).
Parameters: The biochemical parameters and the platelet numbers were measured during five different periods and demonstrated in Table 2. Regarding the free Hb levels, the results in these time periods were not statistically different. Also, the Hp, LDH, and K+ levels did not differ in either group in any of these periods. The preoperative mean platelet number value of the P group was lower than in the NP group (189.670 versus 236.960; p=0.038). In the 30 and 60th minutes of the perfusion period, the mean platelet counts were lower in the P group, but the difference did not reach a significant degree, and the other mean values were not different. The urine Hb levels were significantly higher in the P group in the 30th minute of CPB when compared with the NP cases (41.07±86.7 versus 3.86±13.2; p=0.032). Though insignificant, this parameter was also higher in the 60th minute and in the postoperative measurements. There was no difference regarding total chest drainage amounts (974.07±453.8 versus 987.5±573.2 ml) and number of transfused erythrocyte cell packages (3.63±2.45 versus 3.38±2.41) between the groups.
On the other hand, this type of pulsatile usage has not gained enough worldwide approval, despite its positive effects. The main reason for such hesitation may be the existence of documents claiming the hemolytic effects of pulsatility. Hemolysis is a fact in all extracorporeal circuits, as shown in various studies by the increasing levels of plasma-free Hb and decreasing levels of Hp both during and after CPB.[11] In our study, the effects of pulsatile and nonpulsatile perfusion were investigated in terms of various hemolysis parameters, amount of chest drainage, and transfusion requirement.
The first of the hemolysis parameters is Hb, which is the major erythrocyte protein. Measurement of free Hb in serum can be used as one of the markers of hemolysis.[12] One study by Zumbro et al.[13] demonstrated that as a marker of blood trauma, the plasma Hb level was significantly higher in the pulsatile group compared with the group receiving NP perfusion.[14] On the other hand, this investigation detected no significant difference in platelet levels between the P and NP groups. In our study, the two groups were compared in terms of Hb levels in the preoperative stage, 30 and 60 minutes after initiating of CPB, and at 2 and 24 hours postoperatively. There was no statistically significant difference between the groups within these phases.
Because of the oxidative and toxic properties of the iron-containing heme in Hb, free Hb is bound by the plasma glycoprotein Hp, which is released from the erythrocytes. Haptoglobin is involved in promoting the clearance of plasma Hb.[15] It has a strong affinity to bind Hb and, therefore, inhibits its oxidative activity. The Hp-Hb complex is then removed by the reticuloendothelial system (mostly the spleen and hepatic parenchymal cells). When Hb release increases, the rate of Hp clearance also increases, and the plasma Hp concentration falls.[15] Accordingly, decreased plasma Hp concentration is indicative of increased hemolysis. This parameter is widely used to monitor the intravascular hemolytic processes. Haptoglobin was also measured in our study, and its levels were compared in the five periods. Lower levels were detected for the P group at the 60th minute and in the postoperative measurements, but the difference was not significant between the groups.
Lactate dehydrogenase has long been considered a useful clinical marker of intravascular hemolysis. Its serum levels are mildly elevated in extravascular hemolysis, such as immune hemolytic anemia, but are substantially elevated with intravascular hemolysis, for example thrombotic thrombocytopenic purpura and paroxysmal nocturnal hemoglobinuria.[16] Also, the levels of LDH did not differ between the groups during our study.
Raised K+, similar to hemolysis, refers to a high level of the electrolyte K+ that points to an underlying cause of excessive breakdown of red blood cells. Although a slight increase has been noticed in the P group, the difference was not statistically significant between the groups.
The platelet count was significantly higher in the NP group, but this measurement was obtained in the preoperative period. Since the patients were randomly assigned to the groups, this result can be stated as accidental. In the 30th and 60th m inutes of the perfusion period, the mean platelet counts were lower in the P group, but the difference did not reach significant levels.
Urine Hb was also measured in our study as one of the hemolytic parameters. Hemoglobinuria is associated with indices of intravascular hemolysis. It occurs only after the plasma binding capacity for Hb has been saturated and free Hb is filtered though the glomeruli. It has been suggested that 0.3-0.6 gr/L free Hb is the renal threshold for hemoglobinuria.[17] In the 30th minute of perfusion, urine Hb was significantly higher in the P group, indicating a hemolytic effect. Though the difference was not significant, the urine Hb levels in the P group were higher throughout the study.
The type of perfusion is not always responsible for the hemolysis. For example, a study has shown that excessive usage of a coronary sucker can be blamed for the hemolysis effect. This is dependent on the CPB time and the type of surgical intervention.[18] Our findings showed that total chest drainage amounts and number of transfused erythrocyte cell packages did not differ between the groups.
In conclusion, the only noteworthy finding of hemolytic effect of pulsatile perfusion can be detected in urine Hb measurements. Other findings indicate a clinically insignificant hemolytic effect of pulsatile perfusion which, therefore, supports the recommendation of the pulsatile version of perfusion during CPB.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect
to the authorship and/or publication of this article.
Funding
The authors received no financial support for the
research and/or authorship of this article.
1) Sezai A, Shiono M, Nakata K, Hata M, Iida M, Saito A, et
al. Effects of pulsatile CPB on interleukin-8 and endothelin-1
levels. Artif Organs 2005;29:708-13.
2) Steed DL, Follette DM, Foglia R, Maloney JV, Buckberg
GD. Effects of pulsatile assistance and nonpulsatile flow on
subendocardial perfusion during cardiopulmonary bypass.
Ann Thorac Surg 1978;26:133-41.
3) Mori F, Ivey TD, Itoh T, Thomas R, Breazeale DG, Misbach
G. Effects of pulsatile reperfusion on postischemic recovery
of myocardial function after global hypothermic cardiac
arrest. J Thorac Cardiovasc Surg 1987;93:719-27.
4) Bixler TJ, Magee PG, Flaherty JT, Gardner TJ, Gott VL.
Beneficial effects of pulsatile perfusion in the hypertrophied
ventricle during ventricular fibrillation. Circulation 1979;
60:141-6.
5) Dunn J, Peterson A, Kirsh MM. Effects of pulsatile perfusion
upon left ventricular function. J Surg Res 1978;25:211-6.
6) Nagaoka H, Innami R, Arai H. Effects of pulsatile
cardiopulmonary bypass on the renin-angiotensinaldosterone
system following open heart surgery. Jpn J Surg
1988;18:390-6.
7) Minami K, Körner MM, Vyska K, Kleesiek K, Knobl
H, Körfer R. Effects of pulsatile perfusion on plasma
catecholamine levels and hemodynamics during and after
cardiac operations with cardiopulmonary bypass. J Thorac
Cardiovasc Surg 1990;99:82-91.
8) Philbin DM, Levine FH, Kono K, Coggins CH, Moss
J, Slater EE, et al. Attenuation of the stress response to
cardiopulmonary bypass by the addition of pulsatile flow.
Circulation 1981;64:808-12.
9) Silistreli E, Catalyurek H, Sariosmanoglu N, Acikel U,
Hazan E, Oto O. Effects on the endocrine system of
pulsatile and nonpulsatile perfusion in heart surgery. Asian
Cardiovasc Thorac Ann 1999;7:18-22.
10) Silistreli E, Karacelik M, Buyukgebiz A, Dereli NA, Ozmen
O, Hazan E, et al. Comparing the effects of pulsatile and
nonpulsatile perfusion on Insulin-Glucose metabolism in
diabetic patients in open heart surgery. Turk Gogus Kalp
Dama 1999;7:11-6.
11) Vercaemst L. Hemolysis in cardiac surgery patients
undergoing cardiopulmonary bypass: a review in search
of a treatment algorithm. J Extra Corpor Technol
2008;40:257-67.
12) Na N, Ouyang J, Taes YE, Delanghe JR. Serum free hemoglobin concentrations in healthy individuals are related
to haptoglobin type. Clin Chem 2005;51:1754-5.
13) Zumbro GL Jr, Shearer G, Fishback ME, Galloway RF. A
prospective evaluation of the pulsatile assist device. Ann
Thorac Surg 1979;28:269-73.
14) Alghamdi AA, Latter DA. Pulsatile versus nonpulsatile
cardiopulmonary bypass flow: an evidence-based approach.
J Card Surg 2006;21:347-54.
15) Chukwuemeka AO, Turtle MR, Trivedi UH, Venn GE,
Chambers DJ. A clinical evaluation of platelet function,
haemolysis and oxygen transfer during cardiopulmonary
bypass comparing the Quantum HF-6700 to the HF-5700
hollow fibre membrane oxygenator. Perfusion 2000;15:479-84.
16) Tabbara IA. Hemolytic anemias. Diagnosis and management.
Med Clin North Am 1992;76:649-68.